BARCLAYS PLC - INNATE PHARMA S A ownership

Back to all holdings Add to watchlist

INNATE PHARMA S A's ticker is IPHA and the CUSIP is 45781K204. A total of 1 filers reported holding INNATE PHARMA S A in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
BARCLAYS PLC ownership history of INNATE PHARMA S A
ValueSharesWeighting
Q3 2023$10.0%4120.0%0.00%–
Q2 2023$10.0%4120.0%0.00%–
Q1 2023$1
-50.0%
4120.0%0.00%–
Q4 2022$2–412
+235.0%
0.00%–
Q3 2022$0
-100.0%
123
-94.4%
0.00%–
Q2 2022$6,000
-45.5%
2,179
-36.1%
0.00%–
Q1 2022$11,000–3,411–0.00%–
 Download
Other shareholders
INNATE PHARMA S A shareholders Q4 2023
NameSharesValueWeighting ↓
EXCHANGE TRADED CONCEPTS, LLC 34,998$88,5450.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MILLENNIUM MANAGEMENT LLC 46,973$118,8420.00%
MORGAN STANLEY 44,954$113,7340.00%
Steward Partners Investment Advisory, LLC 500$1,2650.00%
Optiver Holding B.V. 190,219$481,2540.00%
BARCLAYS PLC 412$10.00%
UBS Group AG 146$3690.00%
RHUMBLINE ADVISERS 205$5180.00%
View complete list of INNATE PHARMA S A shareholders